Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Organ Transplantation Techniques and Outcomes, and Liver Diseases and Immunity.
Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPS
Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort Study
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injury
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensus
Cardiovascular comorbidities predict mortality in acute pancreatitis
Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort study
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a <scp>TIPS</scp>
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD
Ammonia Levels After Transjugular Intrahepatic Portosystemic Shunt Insertion Identify Patients at High Risk of Hepatic Encephalopathy
The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic review
Transjugular intrahepatic portosystemic shunt with ePTFE-covered stentgrafts: incidence and predictors of shunt dysfunction
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study
Proton pump inhibitor use and bone fractures in patients with chronic kidney disease
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
PHES scores have limited impact on the risk of overt HE in patients with minimal HE
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2
Evaluation of Sonographic Muscle Measurement Using Established Muscle Markers
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment